Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CME Accrediting Policies Being Revised As Congress Eyes Compliance Issues

Executive Summary

The Accreditation Council for Continuing Medical Education is proposing revisions to its "Standards for Commercial Support" to further limit the role of sponsors in creating and disseminating the materials

You may also be interested in...

Sharing The Risk: Companies Turn To Multi-Sponsored Educational Programs

Pharma companies are turning to multi-sponsored continuing medical education programs as a way to mitigate risks in a climate where company-sponsored educational programs draw increased scrutiny

CME Standards Spur Changes To Sales Rep Practices, Manufacturer Programs

Pharmaceutical companies will be implementing new procedures for sales representative involvement in continuing medical education following updated standards from the Accreditation Council for Continuing Medical Education

Pfizer To Monitor Off-Label Drug Use Under Neurontin Settlement

Pfizer will provide periodic reports to the HHS Inspector General about off-label use trends for its products under the May 13 settlement of an investigation into the company's promotion of Neurontin




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts